Your browser doesn't support javascript.
loading
Phase 1 study of the PI3Kδ inhibitor INCB040093 ± JAK1 inhibitor itacitinib in relapsed/refractory B-cell lymphoma.
Phillips, Tycel J; Forero-Torres, Andres; Sher, Taimur; Diefenbach, Catherine S; Johnston, Patrick; Talpaz, Moshe; Pulini, Jennifer; Zhou, Li; Scherle, Peggy; Chen, Xuejun; Barr, Paul M.
Affiliation
  • Phillips TJ; Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI.
  • Forero-Torres A; Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL.
  • Sher T; Mayo Clinic, Jacksonville, FL.
  • Diefenbach CS; Perlmutter Cancer Center, New York University School of Medicine, New York, NY.
  • Johnston P; Mayo Clinic, Rochester, MN.
  • Talpaz M; Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI.
  • Pulini J; Incyte Corporation, Wilmington, DE.
  • Zhou L; Incyte Corporation, Wilmington, DE.
  • Scherle P; Incyte Corporation, Wilmington, DE.
  • Chen X; Incyte Corporation, Wilmington, DE.
  • Barr PM; Wilmot Cancer Institute, University of Rochester, Rochester, NY.
Blood ; 132(3): 293-306, 2018 07 19.
Article in En | MEDLINE | ID: mdl-29695516
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Lymphoma, B-Cell / Janus Kinase 1 / Class I Phosphatidylinositol 3-Kinases Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2018 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Lymphoma, B-Cell / Janus Kinase 1 / Class I Phosphatidylinositol 3-Kinases Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2018 Type: Article